Protection against reinfection with SARS-CoV-2 omicron BA.2.75<sup>*</sup>sublineage-Reference-Cited by-同舟云学术

Protection against reinfection with SARS-CoV-2 omicron BA.2.75^*sublineage

Published:2022-10-30 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Chemaitelly Hiam^ORCID,Tang Patrick^ORCID,Coyle Peter^ORCID,Yassine Hadi M.^ORCID,Al-Khatib Hebah A.,Smatti Maria K.,Hasan Mohammad R.,Ayoub Houssein H.^ORCID,Altarawneh Heba N.^ORCID,Al-Kanaani Zaina^ORCID,Al-Kuwari Einas,Jeremijenko Andrew^ORCID,Kaleeckal Anvar H.^ORCID,Latif Ali N.,Shaik Riyazuddin M.,Abdul-Rahim Hanan F.^ORCID,Nasrallah Gheyath K.^ORCID,Al-Kuwari Mohamed G.^ORCID,Butt Adeel A.,Al-Romaihi Hamad E.,Al-Thani Mohamed H.,Al-Khal Abdullatif,Bertollini Roberto,Abu-Raddad Laith J.^ORCID

Abstract

Publisher

Cold Spring Harbor Laboratory

Reference50 articles.

1. Sheward DJ , Kim C , Fischbach J , et al. Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies. Lancet Infect Dis 2022.

2. Ayoub HH , Tomy M , Chemaitelly H , et al. Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design. medRxiv 2022:2022.01.02.22268622.

3. Altarawneh HN , Chemaitelly H , Ayoub HH , et al. Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants. New England Journal of Medicine 2022.

4. Chemaitelly H , Ayoub HH , Tang P , et al. Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2. N Engl J Med 2022.

5. Chemaitelly H , Nagelkerke N , Ayoub HH , et al. Duration of immune protection of SARS-CoV-2 natural infection against reinfection. J Travel Med 2022.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of BNT162b2 antigen dosage on protection against SARS-CoV-2 omicron infection;2022-12-08

2. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting;2022-11-15

3. Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline;Viruses;2022-11-10